Yifeng Pharmacy Chain Co Ltd (603939)

Currency in CNY
23.93
-0.03(-0.13%)
Closed·

603939 Financial Summary

Key Ratios

P/E Ratio22.18
Price/Book3.05
Debt / Equity42.21%
Return on Equity14.81%
Dividend Yield2.72%
EBITDA2.47B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.30%
Dividend Yield
2.72%
Industry Median 1.85%
Annualised payout
0.65
Paid unevenly
5-Years Growth
+36.45%
Growth Streak

Analyst Ratings

13 Buy
1 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 35.02
(+46.34% Upside)

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.36 / 0.3484
Revenue / Forecast
6.01B / 6.32B
EPS Revisions
Last 90 days

FAQ

What were Yifeng Pharmacy Chain's earnings for the latest quarter?

The Yifeng Pharmacy Chain EPS (TTM) is 1.30. Yifeng Pharmacy Chain reported sales of 6,009.04, net income of 449.49, and EPS of 0.36 for the latest quarter.

What was Yifeng Pharmacy Chain's net income for the latest quarter?

Yifeng Pharmacy Chain's net income for the latest quarter was 449.49.

How did Yifeng Pharmacy Chain's performance compare year-over-year in the latest quarter?

The company's revenue moved from 6,843.26 in the previous quarter to 6,009.04 in the latest quarter, and net income moved from 418.08 to 449.49 compared to the previous quarter.

What is Yifeng Pharmacy Chain's net profit margin on a TTM basis?

Yifeng Pharmacy Chain's trailing twelve months (TTM) net profit margin is 6.35%.

How does Yifeng Pharmacy Chain's debt to equity ratio compare to industry standards?

Yifeng Pharmacy Chain's total debt-to-equity ratio is 42.21%.

What is Yifeng Pharmacy Chain's return on investment on a TTM basis?

Yifeng Pharmacy Chain's trailing twelve months (TTM) return on investment (ROI) is 14.81%.

Did Yifeng Pharmacy Chain gain or lose cash last quarter?

In the latest quarter, Yifeng Pharmacy Chain's net change in cash was 479.95 million.

What were Yifeng Pharmacy Chain's total assets and liabilities in the latest quarter?

As of the latest quarter, Yifeng Pharmacy Chain reported total assets of 27,786.56 million and total liabilities of 12,103.47 million.

How has Yifeng Pharmacy Chain's total revenue grown this year?

Yifeng Pharmacy Chain's total revenue was 6,843.26 in the previous quarter and 6,009.04 in the latest quarter.

What is Yifeng Pharmacy Chain's gross margin on a TTM basis?

Yifeng Pharmacy Chain's trailing twelve months (TTM) gross margin is 39.87%.

What was Yifeng Pharmacy Chain's revenue per share for the latest quarter?

Yifeng Pharmacy Chain's revenue per share for the latest quarter was 15.23.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.